Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma

Br J Haematol. 2020 Feb;188(4):e33-e36. doi: 10.1111/bjh.16302. Epub 2019 Dec 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Lenalidomide / administration & dosage*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / mortality*
  • Male
  • Middle Aged
  • Risk Factors
  • Survival Rate

Substances

  • Lenalidomide